Here are relevant reports on : multiple-myeloma-market
-
Global Multiple Myeloma Drugs Market
2008 saw almost 12 million patients diagnosed with cancer. Despite, increasing technological advancements and research the deaths due to cancer were about 8 million people in 2008. Lung cancer accounts for the highest mortality rate. There has been a significant development in technologies and drugs/vaccines with respect to breast cancer, thyroid cancer, and pancreatic cancer therefore increasing the survival rates.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
CAR T-Cell Therapy Market by Product (Abecma, Breyanzi, Carvykti, Yescarta, Tecartus, Kymriah), Target (CD19, BCMA), Indication (Multiple Myeloma, Leukemia, Lymphoma), Demographic (Adult, Pediatric), Region, Competitive Landscape - Global Forecast to 2031
The global CAR T-cell therapy market, valued at USD 5.98 billion in 2025, stood at USD 6.78 billion in 2026 and is projected to advance at a resilient CAGR of 14.9% from 2026 to 2031, culminating in a forecasted valuation of USD 13.56 billion by the end of the period. The global CAR T-cell therapy market is growing due to rapid technological advances alongside rising investments from large pharma and well-funded biotech's.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Minimal Residual Disease Market by Product (Kits, Instruments), Technology (PCR, NGS), Application (Leukemia, Lymphoma, Multiple Myeloma, Solid Tumors), End User (Hospitals, Diagnostic Labs, Research Institutes), & Region - Global Forecast to 2029
The global minimal residual disease testing market, valued at US$1.27 billion in 2023, stood at US$1.43 billion in 2024 and is projected to advance at a resilient CAGR of 12.2% from 2024 to 2029, culminating in a forecasted valuation of US$2.55 billion by the end of the period. The market is driven by the growing prevalence of cancer globally and increasing funding from international organizations and governments for cancer prevention programs.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Europe Leukapheresis Market by Product (Devices, Disposable, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), Application (Research, Therapeutic), End User (Hospitals, Pharma, Biotech) - Forecast to 2031
The Europe Leukapheresis market, valued at USD 22.6 million in 2025, stood at USD 24.2 million in 2026 and is projected to advance at a resilient CAGR of 7.1% from 2026 to 2031, culminating in a forecasted valuation of USD 34.1 million by the end of the period. This growth is due to the increasing number of applications for leukapheresis in cases pertaining to hematological disorders, coupled with an increase in the number of starting materials for cell & gene therapy applications.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Railway Connectors Market by Application (Diesel Multiple Units (DMUs), Electric Multiple Units (EMUs), Light Rails/Trams, Subways/Metros, Passenger Coaches), Platform, Component, Connector Type, and Region - Global Forecast to 2023
The railway connectors market is expected to grow from USD 802 million in 2018 to USD 1,069 million by 2023, at a Compound Annual Growth Rate (CAGR) of 5.92% during the forecast period. Increased demand for different types of wagons is a major factor driving the growth of the railway connectors market. Wagons are rail vehicles used to carry passengers and freights. These vehicles are not equipped with propulsion systems and hence, are drawn by locomotives. The demand for wagons is continuously growing in countries such as the US, the UK, France, etc., due to increased industrial activities. Major vendors in the railway connectors market include are TE Connectivity (Switzerland), Amphenol Corporation (US), Molex Incorporated (US), ITT (US), Smiths Interconnect (US), Fischer Connectors (Switzerland), Esterline Technologies (US), Schaltbau (Germany), and Sichuan Yonggui Science and Technology (China).
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Gyros FOG / RLG Market (Single Axis, Multiple Axis), By Products, Technology, Application & Geography - 2019
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Smart Antenna Market: Adaptive Array Antennas, Multiple Antennas, MIMO - Global Forecast and Analysis (2012 - 2017)
A smart antenna is a digital wireless communications antenna system that takes advantage of diversity effect at the transmitter, the receiver, or both. Diversity effect involves the transmission and/or reception of multiple radio frequency (RF) waves to increase data speed and reduce the error rate.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Remote Towers Market by Operation Type (Single, Multiple, Contingency), System Type (Airport Equipment, Remote Tower Modules, Solutions & Software), Application (Communication, Information & Control, Surveillance) and Region - Global Forecast to 2027
The remote towers market industry is projected to grow from USD 0.3 billion in 2022 and to reach USD 0.6 billion by 2027, at a Compound Annual Growth Rate (CAGR) of 19.6% during the forecast period. Saab (Sweden), Thales Group (France), Frequentis Group (Austria), Indra Sistemas (Spain), and L3Harris Technologies (US) are some of the leading players operating in the remote towers market. These key players offer remote towers technology across the North America, European, Asia Pacific, Middle East & Africa and South America.
- Published: May 2022
- Price: $ 4950
- TOC Available:
-
Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD) - Global Forecast to 2024
The electronic drug delivery system market is expected to grow from USD 7.8 billion in 2019 to USD 11.9 billion by 2024, at a compound annual growth rate (CAGR) of 8.7%. during the forecast period.The prominent players in the electronic drug delivery systems market are Insulet Corporation (US), Bayer AG (Germany), Medtronic (Ireland), Novo Nordisk A/S (Denmark), Companion Medical (US), F.Hoffmann-La Roche Ltd (Switzerland), United Therapeutics Corporation (US), AstraZeneca (UK), Tandem Diabetes Care (US), Merck Group (Germany), and Amgen (US).
- Published: October 2019
- Price: $ 4950
- TOC Available:
-
E.coli Test Market by test (Environmental (Membrane Filtration, Multiple Tube Fermentation), Clinical (Polymerase Chain Reaction, Enzyme Immunoassays)) End User (Hospital, Diagnostic Laboratories, Physician Offices) - Global Forecasts to 2023
The global E.coli test market is expected to reach USD 2.05 billion by 2023 from USD 1.38 billion in 2018, growing at a CAGR of 8.2%. Increasing awareness regarding hygienic, government regulations regarding water and food management, government funding for performing diagnostic tests, non-government organizations (NGO’s) campaigns on water management, increasing prevalence of diarrhoea cases are the major driving factors for this market.
- Published: July 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
